CAMBRIDGE, Mass., Oct. 25 /PRNewswire/ -- Biogen, Inc. (Nasdaq: BGEN)
today announced that Frank A. Burke, Jr., has been appointed Executive Vice
President, Human Resources. Mr. Burke reports to James C. Mullen, President
and Chief Executive Officer.
(Photo: http://www.newscom.com/cgi-bin/prnh/19990824/BIOLOGO )
Mr. Burke joined Biogen in 1986 after a 12-year career with Allied Signal
Corporation. He has supervised the global human resources function throughout
Biogen's growth from a boutique research organization into a multi-product
global biopharmaceutical company.
Mr. Mullen said, "Frank Burke is an outstanding professional who has
devoted much of his career to building Biogen. He continues to meet the
considerable challenges of managing the human resources aspects of a dynamic
and rapidly growing organization and will play a key role in the ongoing
evolution of our company."
Biogen, Inc., winner of the U.S. National Medal of Technology, is a
biopharmaceutical company principally engaged in discovering and developing
drugs for human healthcare through genetic engineering. Headquartered in
Cambridge, MA, the Company's revenues are generated from international sales
of AVONEX(R) (Interferon beta-1a) for treatment of relapsing forms of multiple
sclerosis, and from the worldwide sales by licensees of a number of products,
including alpha interferon and hepatitis B vaccines and diagnostic products.
Biogen's research and development activities are focused on novel products to
treat inflammatory and autoimmune diseases, neurological diseases, cancer,
fibrosis and congestive heart failure. The Company maintains active clinical
research programs in protein therapeutics, small molecules, genomics and gene
therapy. For copies of press releases and additional information about the
Company, please consult Biogen's Homepage on the World Wide Web at
http://www.biogen.com.
Media Contact:
Kathryn R. Bloom
Senior Director, Public Affairs
Biogen, Inc.
Tel: (617) 679-2851
Investment Community Contact:
Elizabeth Woo
Associate Director, Investor Relations
Biogen, Inc.
Tel: (617) 679-2822
SOURCE Biogen, Inc.
 back to top
Related links:
http://www.biogen.com
Photo Notes:
NewsCom:
http://www.newscom.com/cgi-bin/prnh/19990824/BIOLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, 888-776-6555 or 212-782-2840
Company News On-Call:
http://www.prnewswire.com/comp/101550.html
CONTACT:
Kathryn R. Bloom, Senior Director, Public
Affairs, +1-617-679-2851, or Elizabeth Woo, Associate Director,
Investor Relations, +1- 617-679-2822, both of Biogen, Inc.
|
